Rationale and design of the PACE HFpEF trial: Physiologic accelerated pacing as a holistic treatment of heart failure with preserved ejection fraction
Authors:
Open Access
- 7 December 2023
- journal article
- research article
- Published by Elsevier in Heart Rhythm O2
- Vol. 5 (1) , 41-49
Abstract
No abstract availableKeywords
Funding Information
- Heart Rhythm Society
- University of Minnesota
- U.S. Food and Drug Administration
- University of Vermont
- Medtronic Inc
- Cardiovascular Research Institute of Vermont, Larner College of Medicine, University of Vermont
- Medtronic
This publication has 38 references indexed in Scilit:
- Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection FractionJAMA, 2016
- Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection FractionCirculation: Heart Failure, 2014
- Ivabradine in Stable Coronary Artery Disease without Clinical Heart FailureNew England Journal of Medicine, 2014
- Spironolactone for Heart Failure with Preserved Ejection FractionNew England Journal of Medicine, 2014
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection FractionJAMA, 2013
- Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection FractionCirculation: Heart Failure, 2011
- Contractile Behavior of the Left Ventricle in Diastolic Heart FailureCirculation, 2006
- Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenololJACC, 2005
- Cardiomyocyte Stiffness in Diastolic Heart FailureCirculation, 2005
- Preferences for treatment outcomes in patients with heart failure: Symptoms versus survivalJournal of Cardiac Failure, 2000